SARS-COV-2 ANTIBODIES IN BIOBLOCK NASAL SPRAY PROVEN TO SUPPRESS DELTA VARIANT
Read more
A NEW BATCH OF BIOBLOCK NASAL SPRAY ARRIVED IN PHARMACIES
Read more
CLINICAL TRIALS OF BIOBLOCK NASAL SPRAY WITH CORONAVIRUS ANTIBODIES ARE BEGINNING
Read more
AS CHEMI-PHARM AND INNOPOLIS INSENERID OÜ ENTERED INTO AN AGREEMENT FOR THE DESIGN OF A PHARMACEUTICAL FACTORY
Read more
TECHNOLOGY FOR THE MANUFACTURE OF SARS-COV-2 BIOBLOCK NASAL AND THROAT SPRAY BASED ON ANTIBODIES AGAINST SARS-COV-2 CORONA VIRUS WAS DEVELOPED AND PATENTED IN COOPERATION BETWEEN COMPANIES AND UNIVERSITIES
Read more
“IMPROVING THE PRODUCTION OF DISINFECTANTS THROUGH FULL AUTOMATION”
Read more
WITH THE HELP OF THE ESTONIAN-NORWEGIAN COOPERATION PROJECT GREEN ICT, CHEMI-PHARM’S PRODUCTION PROCESS WILL BE MORE EFFICIENT AND THERE WILL BE A REMARKABLE INCREASE OF UNITS PRODUCED WITHIN THE SAME WORKING HOURS
Read more
PREVENTION AND DISINFECTION: NOVEL CORONAVIRUS (2019-NCOV; WUHAN CORONAVIRUS)
Read more
